December 2020
IBM has uncovered a global phishing campaign targeting the COVID-19 vaccine cold chain. Attacks seem focused on companies and organisations associated with Gavi, the Vaccine Alliance’s Cold Chain Equipment Optimization Platform:
The UK’s Medicines & Healthcare Products Regulatory Agency (MHRA) has granted a temporary authorisation for emergency use to Pfizer and its German partner BioNTech’s mRNA vaccine, BNT162b2, for Covid-19:
UK GPs will be prioritised for Covid vaccination based on their personal risk level, exposure and amount of contact with vulnerable people, says the UK Joint Committee on Vaccination and Immunisation:
The Institute of Biomedical Science (IBMS), with members in 73 countries, rightly recognises the key contribution laboratory staff have made, and will continue to make, in tackling COVID-19 while maintaining high-quality healthcare services:
Moderna has announced that the primary efficacy analysis data from the Phase III COVE study of mRNA-1273 indicated 100% vaccine efficacy against severe Covid-19:
A new report, "Phase I Study Trends and Market Outlook (2020-2024)" is designed to provide readers with a high-level view of the Phase I clinical development space to illustrate current market dynamics and inform strategic planning:
Queensland, Australia, has emerged as “the Hollywood of the global clinical trial industry.” Now there is a new online portal that links global organisations wanting to conduct clinical trials with research groups, public and private health care providers, universities, and manufacturers across the state:
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has released a guidance document on managing access to electronic personal health data processed during clinical trials. The document is specifically aimed at sponsors, contract research organisations (CROs) and investigator sites:
uk.practicallaw.thomsonreuters.com
The latest announcements from the U.S. Food and Drug Administration on actions taken in its ongoing response effort to the COVID-19 pandemic:
José Baselga, executive vice president, oncology research and development at AstraZeneca, says Covid-19 could accelerate cancer clinical trials
Increasing prevalence of chronic diseases and infections will drive the clinical laboratory service market according to new research by Transparency Market Research:
Research technology company uMed has raised £3.7m in venture capital to help healthcare providers in the UK and US, including GPs, hospitals and health specialists, run patient research more efficiently and safely.
